# To Explore the Influence of Appetite Reduction and Medication Effect of Methylphenidate in Patients With Attention-deficit/Hyperactivity Disorder(ADHD) Through Pharmacogenetics.

> **NCT04006548** · — · COMPLETED · sponsor: **Chang Gung Memorial Hospital** · enrollment: 110 (actual)

## Conditions studied

- Methylphenidate Adverse Reaction

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04006548
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-01
- **Primary completion:** 2022-02-01
- **Final completion:** 2022-02-01
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2022-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04006548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04006548, "To Explore the Influence of Appetite Reduction and Medication Effect of Methylphenidate in Patients With Attention-deficit/Hyperactivity Disorder(ADHD) Through Pharmacogenetics.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04006548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*